• Spyre Therapeutics, Inc. (NASDAQ:SYRE) Given Consensus Recommendation of "Buy" by Analysts

    المصدر: Buzz FX / 17 فبراير 2025 01:35:12   America/Chicago


    Spyre Therapeutics, Inc. (NASDAQ:SYRE) Given Consensus Recommendation of "Buy" by Analysts Written by MarketBeat February 17, 2025 Share Link copied to clipboard. Spyre Therapeutics, Inc. ( NASDAQ:SYRE - Get Free Report ) has received a con
    Read more...
شارك على،